首页> 外文OA文献 >Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct.
【2h】

Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct.

机译:从细胞因子刺激的血管平滑肌细胞释放的稳定的L-精氨酸衍生的松弛因子表征为NG-羟基-L-精氨酸一氧化氮加合物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The nature of an L-arginine-derived relaxing factor released from vascular smooth muscle cells cultured on microcarrier beads and stimulated for 20 h with interleukin 1 beta was investigated. Unlike the unstable relaxation elicited by authentic nitric oxide (NO) in a cascade superfusion bioassay system, the effluate from vascular smooth muscle cells induced a stable relaxation that was susceptible to inhibition by oxyhemoglobin. Three putative endogenous NO carriers mimicked this stable relaxing effect: S-nitroso-L-cysteine, low molecular weight dinitrosyl-iron complexes (DNICs), and the adduct of NG-hydroxy-L-arginine (HOArg) with NO. Inactivation of S-nitroso-L-cysteine by Hg2+ ions or trapping of DNICs with agarose-bound bovine serum albumin abolished their relaxing effects, whereas that of the vascular smooth muscle cell effluate remained unaffected. In addition, neither S-nitrosothiols nor DNICs were detectable in the effluate from these cells, as judged by UV and electron spin resonance (ESR) spectroscopy. The HOArg-NO adduct was instantaneously generated upon reaction of HOArg with authentic NO under bioassay conditions. Its pharmacological profile was indistinguishable from that of the vascular smooth muscle cell effluate, as judged by comparative bioassay with different vascular and nonvascular smooth muscle preparations. Moreover, up to 100 nM HOArg was detected in the effluate from interleukin 1 beta-stimulated vascular smooth muscle cells, suggesting that sufficient amounts of HOArg are released from these cells to spontaneously generate the HOArg-NO adduct. This intercellular NO carrier probably accounts for the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells and also from other NO-producing cells, such as macrophages and neutrophils.
机译:研究了从L型精氨酸衍生的松弛因子的性质,该松弛因子从培养在微载体珠上的血管平滑肌细胞释放并用白介素1β刺激20小时。与级联超融合生物测定系统中的真实一氧化氮(NO)引起的不稳定弛豫不同,来自血管平滑肌细胞的流出物诱导了稳定的弛豫,易受氧合血红蛋白的抑制。三种假定的内源性NO载体模拟了这种稳定的松弛作用:S-亚硝基-L-半胱氨酸,低分子量二亚硝酰基-铁络合物(DNIC),以及NG-羟基-L-精氨酸(HOArg)与NO的加合物。 Hg2 +离子灭活S-亚硝基L-半胱氨酸或用琼脂糖结合的牛血清白蛋白捕获DNIC消除了它们的松弛作用,而血管平滑肌细胞流出物的松弛作用仍然不受影响。此外,通过紫外线和电子自旋共振(ESR)光谱学判断,在这些细胞的流出物中均未检测到S-亚硝基硫醇或DNIC。在生物测定条件下,HOArg与真实的NO反应后立即生成HOArg-NO加合物。如通过比较生物测定法对不同血管和非血管平滑肌制剂的比较,其药理作用与血管平滑肌细胞流出物的药理作用没有区别。此外,在白介素1β刺激的血管平滑肌细胞的流出物中检测到高达100 nM HOArg,这表明从这些细胞中释放出足够量的HOArg,以自发产生HOArg-NO加合物。这种细胞间NO载体可能是由细胞因子刺激的血管平滑肌细胞以及其他产生NO的细胞(例如巨噬细胞和嗜中性粒细胞)释放的稳定的L-精氨酸衍生的松弛因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号